Your browser doesn't support javascript.
loading
Predictors of time to initiation of symptomatic therapy in early Parkinson's disease.
Simuni, Tanya; Long, Jeffrey D; Caspell-Garcia, Chelsea; Coffey, Christopher S; Lasch, Shirley; Tanner, Caroline M; Jennings, Danna; Kieburtz, Karl D; Marek, Kenneth.
Afiliación
  • Simuni T; Neurology Parkinson's Disease and Movement Disorders Center Northwestern University Chicago Illinois.
  • Long JD; University of Iowa iowa City Iowa.
  • Caspell-Garcia C; Clinical Trials Statistical & Data Management Center University of Iowa College of Public Health iowa City iowa.
  • Coffey CS; Clinical Trials Statistical & Data Management Center University of Iowa College of Public Health iowa City iowa.
  • Lasch S; Institute for Neurodegenerative Disorders (IND) Molecular NeuroImaging LLC (MNI) New Haven Connecticut.
  • Tanner CM; Neurology University of California San Francisco California.
  • Jennings D; Institute for Neurodegenerative Disorders (IND) Molecular NeuroImaging LLC (MNI) New Haven Connecticut.
  • Kieburtz KD; Center for Human Experimental Therapeutics University of Rochester Rochester New York.
  • Marek K; Institute for Neurodegenerative Disorders (IND) Molecular NeuroImaging LLC (MNI) New Haven Connecticut.
Ann Clin Transl Neurol ; 3(7): 482-94, 2016 Jul.
Article en En | MEDLINE | ID: mdl-27386498

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Ann Clin Transl Neurol Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Ann Clin Transl Neurol Año: 2016 Tipo del documento: Article